Polypeptide-Based Conjugates as Therapeutics: Opportunities and Challenges
Autores de CIPF
Grupos de Investigación
Abstract
Synthetic polypeptides or polyamino acids have become a useful and multifunctional platform in advanced drug delivery studies. Nonetheless, the full potential of these systems has yet to be achieved. The final structure of polypeptide conjugates and their in vivo behavior are dependent on an extraordinarily complex pattern of interconnected physico-chemical and structural parameters, making sophisticated directional design of such systems difficult and often unachievable. In this review, the authors aim to discuss the role of these parameters in the successful design of different drug delivery architectures and to delineate some basic correlations between structure, properties, and the biological behavior of polypeptide-based conjugates.
Datos de la publicación
- ISSN/ISSNe:
- 1616-5187, 1616-5195
- Tipo:
- Review
- Páginas:
- -
- PubMed:
- 27753211
MACROMOLECULAR BIOSCIENCE WILEY-V C H VERLAG GMBH
Citas Recibidas en Web of Science: 62
Documentos
- No hay documentos
Filiaciones
Keywords
- drug conjugates; drug delivery systems; nanomedicine; polymer therapeutics; polypeptide
Proyectos asociados
Towards the design of Personalised Polymer-based Combiantion Nanomedicines for Advanced Stage Breast Cancer Patients
Investigador Principal: MARIA JESUS VICENT DOCON
COMMISSION OF EUROPEAN COMMUNITIES . 2015
Polímeros Terapéuticos diseñados para cruzar la Barrera Hematoencefálica para el tratamiento de desordenes neurodegenerativos-Explorando la Ruta Intranasal.
Investigador Principal: MARIA JESUS VICENT DOCON
MINISTERIO DE ECON. Y COMPET. . 2016
Desarrollo de un estrategia para la prevención miocárdica del daño inducido por reperfusión basada en el uso de catéteres y polímeros teraéuticos de nueva generación Premicat
Investigador Principal: MARIA JESUS VICENT DOCON
INSTITUTO DE SALUD CARLOS III . 2016